A number of European countries have expressed interest in purchasing unwanted AstraZeneca vaccines from Denmark.
On Wednesday, Denmark became the first European country to abandon AstraZeneca s COVID vaccine due to a link with extremely rare cases of blood clots.
A day later, Norway s Public Health Institute also recommended against further use of the jab.
The decisions raise questions over potential surplus batches of the AstraZeneca vaccine (Vaxzevria) in both countries, including a reported 200,000 doses in Denmark.
On Thursday, the director of the World Health Organization (WHO) for Europe, Hans Kluge, said Denmark was considering sharing unused doses with poorer countries.